Sodium phenylbutyrate–ursodoxicoltaurine for treating amyotrophic lateral sclerosis [ID6246]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Amyotrophic lateral sclerosis - SAR443820 [ID6386]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Human immunoglobulin with recombinant human hyaluronidase for maintenance treatment of multifocal motor neuropathy in people of any age TSID 12033Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC